BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 5, 2026
Home » Authors » Kim Coghill

Articles by Kim Coghill

Alkermes Starts Phase III Of Drug For Alcohol Dependence

April 2, 2002
By Kim Coghill

Adolor Moving Analgesic Back To Phase I To Work On Dosing

April 2, 2002
By Kim Coghill

Alkermes Starts Phase III Of Drug For Alcohol Dependence

April 2, 2002
By Kim Coghill

Proposed Bill Would Loosen Research Patent Requirements

April 1, 2002
By Kim Coghill
WASHINGTON - A House Democrat introduced legislation that would allow scientists to conduct research using patented genetic sequence information without obtaining permission from the patent’s owner. (BioWorld Today)
Read More

Proposed Bill Would Loosen Research Patent Requirements

April 1, 2002
By Kim Coghill
WASHINGTON - A House Democrat introduced legislation that would allow scientists to conduct research using patented genetic sequence information without obtaining permission from the patent’s owner. (BioWorld Today)
Read More

Isis’ GeneTrove Signs Pharmacia To Antisense Inhibitor Agreemen

March 28, 2002
By Kim Coghill
Isis Pharmaceuticals Inc. on Wednesday said it signed another major drug company to use its GeneTrove division’s antisense inhibitors for target validation studies. (BioWorld Today)
Read More

Isis’ GeneTrove Signs Pharmacia To Antisense Inhibitor Agreemen

March 28, 2002
By Kim Coghill
Isis Pharmaceuticals Inc. on Wednesday said it signed another major drug company to use its GeneTrove division’s antisense inhibitors for target validation studies. (BioWorld Today)
Read More

Bush Unveils Planned NIH, Surgeon General Nominations

March 27, 2002
By Kim Coghill

ISTA’s Stock Slides On Vitrase Missed Primary Endpoint

March 27, 2002
By Kim Coghill
Wall Street did not look kindly on ISTA Pharmaceuticals’ failure to meet its primary endpoint in two pivotal Phase III studies of Vitrase, a single injection for treating vitreous hemorrhage. (BioWorld Today)
Read More

Bush Unveils Planned NIH, Surgeon General Nominations

March 27, 2002
By Kim Coghill
Previous 1 2 … 126 127 128 129 130 131 132 133 134 … 142 143 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 4, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Art concept for medical research

    MicroRNAs in circulating extracellular vesicles as IPF biomarkers

    BioWorld Science
    MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing